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Abstract 
As the demand for carbon-free fuel sources has increased, hydrogen gas has become a promising 
alternative since it can be produced from water. However, efficient production of H2 requires the 
use of expensive metal catalysts such as platinum. Because of the cost and low availability of 
these metals, scientists have turned to nature as inspiration for the development of metal catalysts 
that use cheaper, more abundant transition metals. One such example of a natural H2 catalyst is 
the mono-iron hydrogenase enzyme, which heterolytically cleaves H2 into a proton and hydride. 
The active site of this enzyme contains a central iron atom surrounded by a nitrogen-bound 
pyridone, an acyl carbon, and a cysteine thiolate donor. This unique arrangement of ligands 
allows the enzyme to activate H2 with the help of the substrate, methenyl-H4MPT
+. Previous 
research by the Rose Group has led to the development of a functional biomimetic model of the 
mono-Fe hydrogenase active site that is capable of activating H2. This biomimetic model can 
accept a hydride from the substrate, but the reverse reaction of hydride transfer to the substrate 
had yet to be observed. To achieve this, obtaining more information about the role of the 
substrate in H2 activation was necessary. This research therefore focused on the synthesis of a 
model imidazolium substrate based on methenyl- H4MPT
+. In reactivity studies with an enzyme 
model, it was determined that altering the Lewis acidity of the model substrate promoted hydride 
transfer from the model complex. With this insight, it is hoped that the interaction between the 
endogenous substrate and the mono-iron hydrogenase active site can be better understood. 
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Introduction 
The world currently relies heavily on hydrocarbon sources such as coal or natural gas for 
energy production. In 2011, over 80% of total primary energy came from fossil fuels. 1 While 
efficient, these sources of energy produce carbon dioxide and other pollutants that damage the 
environment, and they are limited in supply. 1 Hydrogen has recently proven to be a viable and 
cleaner alternative form of energy. Unlike fossil fuels, hydrogen can be produced from the 
electrolysis of water using solar energy. By passing an electric current through water, the H2O 
molecules can be split into oxygen and hydrogen gas.2 If the electricity needed to power 
electrolysis was generated by solar, wind, or nuclear sources, zero greenhouse gasses would be 
produced. Because of this, hydrogen is a promising renewable fuel source.  
However, hydrogen production by electrolysis is not yet efficient for large-scale use. The 
amount of energy required to electrolytically split water into oxygen and hydrogen is ultimately 
more than the energy available from the hydrogen produced.3 Additionally, producing hydrogen 
by electrolysis is more expensive than the more common steam reforming method.4 One reason 
for this high cost is the need for not only electricity, but also expensive metal catalysts such as 
platinum or palladium. Compared to other transition metals, platinum and palladium are more 
expensive and less earth-abundant, posing an economic barrier to electrolysis. Therefore, 
production of H2 as an energy source needs to overcome many hurdles before it will be feasible 
for large-scale energy use.  
One way researchers are trying to solve these issues is through the exploration of new 
hydrogen catalysts. Instead of developing these catalysts from scratch, scientists have turned to 
biology for inspiration. Many microorganisms are able to utilize H2 as an energy source due to the 
presence of several hydrogenase enzymes. In bacteria, this enzyme supplies energy for anaerobic 
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metabolism and can act as an electron acceptor, resulting in the production of H2.
5 In general, the 
hydrogenase enzymes function by activating the H2 bond through interaction with metal(s) in the 
enzyme’s active site. There are currently three phylogenetically distinct forms of hydrogenase that 
are known, each with a unique active site: [Fe-Fe] hydrogenase, [Ni-Fe] hydrogenase, and mono-
[Fe] hydrogenase (Figure 1).  
 
Figure 1. Active sites of [Fe-Fe] hydrogenase (left), [Ni-Fe] hydrogenase (center), and mono-[Fe] hydrogenase (right) 
[Fe-Fe] hydrogenases catalyze the reaction of H2 into protons and electrons (H2 ↔ 2H+ + 
2e-). They are most commonly found in anaerobic prokaryotes or unicellular algae as a way to 
prevent buildup of excess electrons or reducing equivalents.6 As its name suggests, the active site 
of di-iron hydrogenase is composed of two iron atoms, connected by two bridging thiolates and a 
bridging carbonyl. The coordinated CN- ligands are thought to help stabilize the Fe-Fe orientation 
in the protein during catalysis. The CO ligands however are more labile and can take on different 
configurations during the catalytic cycle.7 Due to their high catalytic activity, [Fe-Fe] 
hydrogenases have been extensively studied for hydrogen production. Comparatively, the [Ni-Fe] 
hydrogenase catalyzes the same reversible reaction as [Fe-Fe] hydrogenase, producing protons and 
electrons from H2. Like [Fe-Fe] hydrogenase, this class of hydrogenase also contains an iron-sulfur 
cluster, which is thought to play a role in electron transport. In both enzymes, the active sites are 
coordinated by cysteine residues from the surrounding protein and contain CN- and CO ligands. 
However, this enzyme differs in that it contains a Ni atom in place of one of the Fe atoms in the 
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active site. Additionally, the active site consists of two bridging thiolates, and an open coordination 
site between the Ni and Fe metals. Unlike [Fe-Fe] hydrogenase, [Ni-Fe] hydrogenase appears to 
prefer H2 oxidation over the reverse reaction.
6 However, it has also been frequently studied due to 
its abundance in many types of bacteria, including anaerobic and pathogenic organisms.11 
As the third type of hydrogenase to be discovered, mono-[Fe] hydrogenase is presently the 
least studied. Only relatively recently, in 2009, was a complete crystal structure of the enzyme’s 
active site solved.9 However, valuable information has been learned since then. Mono-[Fe] 
hydrogenase differs from the other hydrogenases in both structure and function. Instead of 
catalyzing the redox reactions of H2, this enzyme heterolytically cleaves H2 into a proton and 
hydride (H2 ↔ H+ + H-). The active site of the mono-[Fe] hydrogenase is unique in that in contains 
a single iron center that is not redox-active. Additionally, it has a unique arrangement of covalently 
bound compounds, called ligands, that assist in hydrogen activation. Unlike the [Fe-Fe] and [Ni-
Fe] active sites, this enzyme does not contain an iron-sulfur cluster or CN- ligands. Instead, mono-
[Fe] hydrogenase relies on coordination by a nitrogen-bound pyridone, an acyl carbon, and a sulfur 
thiolate donor. From previous enzyme models, it is believed that all three of these ligands are 
important for hydrogen activation (Figure 2).8,9 
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Figure 2. Active site of mono-[Fe] hydrogenase with facial arrangement of N, C, and S atoms, Cys176, and an open 
site trans to the acyl unit.9 
 
As the least-studied and most unique class of hydrogenase, it is important to learn more 
about the function of mono-[Fe] hydrogenase. One way this is possible is through the design of 
small molecule mimics of the enzyme active site that display similar catalytic activity to the natural 
enzyme. Typically, enzymes are studied by manipulating single amino acid residues in the active 
site and observing the resulting effects on structural, kinetic, and binding parameters. However, 
the active site of mono-[Fe] hydrogenase contains only a single cysteine residue bound to the Fe 
center, making it less suitable for this type of study. By preparing small molecule mimics of mono-
[Fe] hydrogenase through synthetic organic and inorganic chemistry, the various features of the 
active site (pyridone, thiolate, substrate) can be more easily modulated and studied. Synthetic 
models of [Fe-Fe] and [Ni-Fe] hydrogenases would be useful, but their mechanisms have already 
been more extensively studied. Additionally, they have been shown to be more susceptible to 
oxygen exposure, making reactivity studies difficult.6 The presence of only a single metal center 
in the mono-[Fe] active site makes it not only simpler to model, but important to study for 
comparison to the other hydrogenases. Therefore, one goal of this project is to help characterize 
and evaluate a small model mimic of mono-[Fe] hydrogenase. 
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Looking more closely at the natural enzyme, the role of the substrate is also important for 
hydrogen activation. Mono-[Fe] hydrogenase is commonly found in methanogenic archaea that 
utilize H2 to reduce CO2 to methane.
 Within this process, the enzyme interacts selectively with a 
substrate called methenyltetrahydromethanopterin (methenyl-H4MPT+), and transfers a hydride to 
it, forming methyleneltetrahydromethanopterin (methylene-H4MPT).
10 In nature, the reverse 
reaction can also occur in which methylene-H4MPT transfers the hydride back to the Fe center of 
the active site (Figure 3). From there it can combine with H+ and release H2. An effective synthetic 
model of the enzyme should therefore be able to catalyze H2 ↔ H+ + H- in both directions with the 
assistance of a model substrate. 
 
Figure 3. Role of mono-[Fe] hydrogenase in the reversible reduction of the substrate methenyl-H4MPT+ to methylene-
H4MPT. 
 
In the Rose Group, a current model of mono-[Fe] hydrogenase has shown to be capable of 
catalyzing the reverse reaction in which H2 is produced. This model differs from previous models 
in that it obtains the correct facial chelation of the nitrogen, carbon, and sulfur atoms present in 
the natural enzyme (Figure 4).9 This means that the N, C, and S atoms are all in the same face of 
the central Fe atom. The positioning of an open coordination site trans to the carbamoyl group also 
closely models the natural enzyme. However, it differs from the natural enzyme in that it 
incorporates a pyridine moiety instead of a pyridone, a thioether in place of the natural thiolate, 
and a carbamoyl group (RN-C=O) in place of an acyl group.8 This model is referred to as the Fe-
carbamoyl model due to the presence of the Fe-Ccarbamoyl bond. 
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Figure 4.  Solved crystal structure of mono-[Fe] hydrogenase (left) 9, and comparison of natural enzyme active site 
(middle) with biomimetic Fe-carbamoyl model (right) 
 
Despite these differences, this model has shown promising results. Reactivity studies 
performed with this model showed that in the presence of a base (phenolate), model substrate 
(imidazolidine), and H2 gas, the Fe center was competent for hydride abstraction and producing 
H2 (H
+ + [C-H] → H2 + [C+]). The proposed mechanism for this model complex is shown in Figure 
5. 
 
Figure 5. Proposed mechanism for the reactivity of the Fe-carbamoyl model with H2 in the presence of an 
imidazolidine substrate and 2,6-di-tert-butyl-4-methoxyphenol. 8 
 
In this mechanism, an iodide atom attached to the open site of the iron center (not shown) 
is first replaced by THF. Addition of the model substrate, imidazolidine (Im-H), is thought to 
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produce an intermediate in which the iron center interacts with the nascent hydride from the 
imidazolidine. The hydride eventually transfers completely to the Fe center as evidenced by the 
formation of imidazolium (Im+). Observation of a deprotonated base and H2 gas suggest that the 
reaction is catalytic.8 
One important feature of this mechanism is the role of the imidazolidine substrate (1,3-
bis(2,6-difluorophenyl)-2-(4-tolyl)imidazolidine). For discussion purposes, it will be abbreviated 
Im-H and the dehydrided form (imidazolium) will be abbreviated Im+. In the natural enzyme, the 
substrate involved is methylene-H4MPT. Both the model and natural substrate have the same 
imidazolidine structure (two nitrogen atoms separated by one carbon in a five-member ring). 
Following hydride abstraction, both will form a carbocation in the same position. Their role as 
Lewis acids make them capable of accepting an electron pair, such as from a hydride. This acidity 
also allows them to interact well with a metal center.  Since this is the main site for hydrogen 
activation, it appears that the model imidazolidine is an effective mimic of the natural substrate 
(Figure 6).  
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Figure 6. Comparison of H2 reactivity with the natural mono-[Fe] hydrogenase substrate (top) and with the model 
imidazolium substrate (bottom) 
 
However, using the Fe-carbamoyl model complex, the reverse reaction in which a hydride 
is abstracted from the Fe center by the imidazolium substrate (Im+) has not yet been observed. 
This reaction is necessary to further prove that the enzyme model is catalytic, and functions in both 
the forward and reverse directions like the natural enzyme. The lack of success in observing 
hydrogenation of the imidazolium substrate may be attributed to several important factors. One 
reason may be that the imidazolium (Im+) used in the study was not a strong enough hydride 
acceptor, making it unable to abstract the hydride from the Fe center. It is proposed that increasing 
the Lewis acidity or altering the electronics of the model imidazolium substrate by attaching 
various electron-donating/withdrawing groups to the para position on the imidazolium will assist 
in observing hydride transfer to the substrate. Therefore, one goal of this research will be to 
modulate the electronics of this substrate to determine its role in hydrogen activation by the 
enzyme in both the forward and reverse directions. This paper will discuss the synthesis and 
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resulting reactivity studies of various imidazolium substrates involved in the reactivity of a model 
mono-[Fe] hydrogenase.  
A second reason the reverse hydrogenation reaction may not have been observed could be 
that the model is not as effective as the natural enzyme at adjusting its Lewis acidity/basicity, and 
is presently better suited for hydride abstraction.8 One reason for this modulation difficulty may 
be due to the absence of a pyridone in the model. As stated earlier, the existing model has a pyridine 
in place of the pyridone of the native enzyme. While this does not seem like a large difference, the 
C=O oxygen present in a pyridone is capable of interacting with hydrogen atoms, potentially 
stabilizing them in the active site until the desired reaction has occurred. Through the synthesis of 
pyridone analogs it is hoped that a chemical model closer in structure to the actual mono-[Fe] 
hydrogenase can be synthesized. Substitution of the various pyridone analogs into a working 
model of the enzyme is a long-term goal of this project (not discussed further herein).  
The scope of this research covers the synthesis of various imidazolium compounds to 
determine the importance of the substrate in H2 activation. Reactivity studies with the synthesized 
imidazoliums will probe whether hydride transfer from H2 to the substrate is possible with the 
enzyme model.  
Results and Discussion 
Imidazoliums are derived from the imidazole functional group, which is a heterocyclic 
five-membered aromatic ring containing two nitrogen atoms. An imidazolium is the cationic 
species formed by the addition of hydrogen to an imidazole. It can easily be converted to an 
imidazolidine through addition of a hydride. These compounds are important to many chemical 
and biological fields due to their Lewis acidity.12 The positive charge, which exists as a resonance 
structure between the two nitrogen atoms, allows the imidazolium to accept an electron pair, such 
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as a hydride or a Lewis base. Meyer et al. first described the synthesis of an imidazolium that 
would be a suitable substrate for mono-[Fe] hydrogenase due to its similarity to methenyl-
H4MPT
+.13 Their synthetic approach has been expanded to synthesize six different imidazolium 
derivatives (Figure 7). 
 
Figure 7. Imidazolium derivatives synthesized based off Meyer et al. procedure. The derivatives vary in electron 
donating/withdrawing abilities, causing the overall compounds to have varying Lewis acidities 
 
I. Synthesis of Imidazolium Derivatives 
The synthesis of each imidazolium was achieved through a three-step synthetic route based 
on the procedure of Meyer et al. The first step involved preparation of trimethylsilyl polyphosphate 
(PPSE), a known dehydrating reagent in the synthesis of amines and symmetric amidines (Scheme 
1).14  
 
Scheme 1. Preparation of PPSE with phosphorous pentoxide and hexamethyldisiloxane 
 
This reaction activates hexamethyldisiloxane with phosphorous pentoxide in the presence of 
dichloromethane (DCM) to produce a mixture of cyclic and linear tetraphosphoric acid esters 
(Figure 8). These products comprise the active species in PPSE. Compared to the more commonly 
known reagent polyphosphoric acid (PPA), PPSE is beneficial in the synthesis of amines and 
amidines in that it is aprotic and soluble in organic solvents.15  
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Figure 8. PPSE active species: A) isocyclotetraphosphate, B) cyclotetraphosphate, C) linear tetraphosphate, D) 
pyrophosphate 14 
 
After heating the phosphorous pentoxide and hexamethyldisiloxane to reflux for 1 hour under 
nitrogen, any volatile components including DCM and unreacted siloxane were distilled off at 160 
°C. The resulting PPSE reagent was a viscous tan liquid, which was used for the next synthetic 
step. 
To the obtained viscous syrup, one equivalent of the respective carboxylic acid and 2 
equivalents of amine were added at 160 °C (Scheme 2). Based on the mechanism proposed by 
Kakimoto et al., it is thought that PPSE reacts first with the carboxylic acid to produce a mixed 
anhydride. While PPSE can also react with the amine, performing the reaction at high temperature 
(160 °C) results in the decomposition of any phosphoric amide product back to the initial amidine, 
preventing side reactions. Reaction of the mixed anhydride with the amide and PPSE results in a 
series of phosphorylated intermediates. Dephosphorylation results in formation of an imidate 
intermediate that can react with the amine to produce the final amidine product. 14 To collect the 
final amidine, the reaction was added to KOH and stirred for thirty minutes. The product was then 
recrystallized from a DCM/pentane mixture at -20 °C. While crystallization was observed after 24 
hours, the amidine yields could be increased by leaving the solution at -20 °C for closer to 48 
hours. 
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The carboxylic acid source used in these reactions was varied to produce amidines with 
different groups in the para position. This would result in the synthesis of model imidazolium 
substrates with varying Lewis acid strengths. For example, the use of 4-Br-benzoic acid will 
produce an amidine, and eventually an imidazolium, with a Br atom in the para position. Since Br 
is a strong electron-withdrawing group, it produced an imidazolium that was a strong Lewis acid. 
Addition of 4-methoxybenzoic acid on the other hand, resulted in an electron donating OMe group 
in the para position, making the final imidazolium less Lewis acidic. The amine (2,6-
difluoroaniline) used in this synthesis was the same for all reactions. 
 
Scheme 2. Synthesis of amidines using PPSE reagent, carboxylic acid, and aniline 
 
After structural confirmation by 1H and 19F NMR spectroscopies, the resulting amidine was 
treated with 1,2-dibromoethane for 52 hours at 135 °C, based on the procedure from Meyer et al 
(Scheme 3). This reaction results in closing of the imidazole ring through alkylation with 1,2-
dibromoethane and elimination of HBr. Reaction of a haloalkane to produce a cyclic heterocycle 
has been previously demonstrated in the preparation of not only imidazoliums, but other imidazole 
derivatives.16 After heating for just over 2 days, the unreacted dibromoethane was removed in 
vacuo and the crude product dissolved in DCM. After washing with sodium bicarbonate, the 
organic phase was concentrated. The desired imidazolium salt could then be precipitated upon 
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addition of Et2O. Removal of the ether layer and collection of the product after washing with Et2O 
gave reasonably pure products. However, recrystallization at room temperature for a few hours by 
layering DCM/Et2O was found to increase the purity of the product. 
 
 
Scheme 3. Synthesis of imidazolium from synthesized amidine and 1,2-dibromoethane 
 
One unique aspect of this reaction is that it occurs without any additional solvent. The 
added 1,2-dibromoethane, a liquid, acts as both a reagent and solvent. Additionally, the amidine 
starting material also serves as a base in this reaction, so the maximum yield is 50%. It is 
hypothesized that addition of a different base such as ethyldiisopropylamine, which was used in 
similar reactions, could help increase the final yields.12 Of the prepared imidazolium compounds, 
only the methyl substituted product was previously known. Through the use of other para 
substituted carboxylic acid derivatives, new amidine and imidazolium products were synthesized 
(Table 1). 
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Table 1. Yields of the amidine and imidazolium derivatives based on their corresponding carboxylic acid precursor. 
The maximum yield for the imidazolium compounds is 50% because half of the amidine starting material serves as a 
base in the reaction. 
 
Carboxylic Acid Imidazolium Amidine 
Yield 
Imidazolium 
yield 
 
 
62% 17% 
 
 
89% 34% 
 
 
69% 20% 
 
 
62% 31% 
 
 
73% 20% 
 
 
II. Imidazolium Reactivity based on Lewis Acidity 
Meyer et al. demonstrated catalytic H2 activation with a ruthenium-based [Fe] hydrogenase 
model using the CH3-imidazolium substrate. However, their model lacked similarity to the natural 
enzyme in that it had a Ru center (not Fe) and no nitrogen or sulfur containing ligands.12 It was 
hypothesized that using an imidazolium substrate similar to the Meyer group with a more closely 
related [Fe]- hydrogenase model would more accurately model the natural enzyme. 
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The main reason for synthesizing the para-substituted imidazolium derivatives was for use 
in the study of the model complex reactivity. As stated in the introduction, the [Fe]-carbamoyl 
model complex was capable of abstracting a hydride from the carbon atom of the imidazolidine 
substrate (Im-H). However, the reverse reaction in which the Fe center transfers the hydride back 
to the cationic imidazolium substrate was not observed. One reason could be that the original 
substrate used (CH3-imidazolium) was not a strong enough hydride acceptor to take the hydride 
back from the Fe center. Therefore, by synthesizing the imidazolium derivatives described above, 
the Lewis acidity (and therefore hydride accepting ability) of the substrate could be tuned. 
A second factor that may have been inhibiting hydride transfer to the carbocation of the 
imidazolium was the Lewis acidity/basicity of the model complex. While the natural enzyme has 
the rest of the protein environment to assist in tuning its acidity, the model Fe-carbamoyl complex 
lacks this flexibility. Therefore, altering the structure of the model complex may also be beneficial 
to observe hydride abstraction. For this reason, further studies were completed with the Fe-acyl 
complex, which is similar to the Fe-carbamoyl complex except that it possesses a CH2 group in 
place of the NH group. From initial experiments done with the Fe-acyl complex, it was discovered 
that when reacted with a base (phenolate) the CH2 group of the Fe-acyl compound is deprotonated 
(Scheme 4).8 
 
 
Scheme 4. Deprotonation of Fe-acyl CH2 in the presence of phenolate base 
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Reactivity studies of the Fe-acyl model complex with the imidazolium derivatives are 
ongoing. However, some preliminary results have been obtained. Many of the reactivity results 
presented heretoforward were obtained by a postdoc in our group, Dr. Jun Seo. They are included 
as a critical component to understand the purpose and implications of the functional studies 
performed with the imidazolium derivatives. One important discovery is that the imidazolium is 
necessary to stabilize the Fe-acyl complex in the presence of D2 (or H2) gas. Without the 
imidazolium, decomposition of the complex is observed (Scheme 5). The reactions in Scheme 5 
demonstrate the stabilization by the imidazolium. When the imidazolium is present, an O-D (5.58 
ppm), D2 (4.52 ppm), and two THF peaks (3.58, 1.73 ppm) are observed in the 
2H NMR. There is 
also an Fe-D signal (-14.89 ppm), indicating an interaction with the Fe center. In the absence of 
the imidazolium substrate the O-D (5.77 ppm), D2 (4.53 ppm), and two THF signals (3.58 and 1.73 
ppm) are still present. However, an additional feature at 2.01 ppm and lack of an Fe-D resonance 
indicate decomposition of the Fe-acyl complex after the acyl C-C bond has dissociated. 
Decomposition was also confirmed using IR spectroscopy, which showed a shift in the carbonyl 
stretching frequencies (not shown). Overall, this data suggests that the imidazolium substrate is 
essential not only for H2 activation, but also to stabilize the hydride adduct of the model complex. 
Therefore, H4MPT
+ most likely plays a more important role in H2 activation by mono-[Fe] 
hydrogenase and stabilization of the intermediate iron-hydride species than initially suspected. 
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Scheme 5. Inclusion of imidazolium (bottom) in the reaction helps stabilize the Fe-acyl complex and prevents 
decomposition (top). D2 gas was utilized instead of H2 because it behaves the same way but is easier to track through 
NMR. 
In the reaction depicted in Scheme 5, no base was added to the reaction after addition of 
the imidazolium substrate. This resulted in the deuteride (D-) from D2 going to form Fe-D, while 
D+ protonated the previously formed double bond. While this was beneficial to observe Fe-D 
formation, transfer of the deuteride to the imidazolium substrate (Im-D) was still not observed. In 
order to push the reaction further in an attempt to observe Im-D formation, additional phenolate 
base was added (Figure 9). The 2H NMR data collected from this reaction shows the previously 
observed THF, D2, and Fe-D (-14.90 ppm) signals, but also has new peaks at 6.12 ppm and 5.58 
ppm. These correspond to Im-D and phenol O-D respectively. From these results, it can be 
concluded that addition of the phenolate base to the reaction was successful in promoting transfer 
of the deuteride to the substrate. It is hypothesized that the phenolate interacts with D+ from D2, 
while the imidazolium and Fe center interact with D-. When the phenolate abstracts D+ to form 
phenol (O-D), it encourages transfer of the deuteride to the substrate, thus forming Im-D.  
18 
 
 
Figure 9. Reaction of Im+ phenolate base with the model Fe complex. Im-D, Fe-D, and OD signals are observed in 
2H NMR suggesting partial transfer of the hydride to the substrate. 
 While addition of base allowed for observation of the Im-D signal by 2H NMR, the 
presence of the Fe-D signal indicates that a complete transfer of D- to the substrate did not occur. 
In order to prove that the model complex is catalytic like the enzyme, full transfer to the substrate 
is desired. As stated earlier, changing the Lewis acidity to make the substrate a stronger 
hydride/deuteride acceptor was one proposed solution. Therefore, a similar reaction to Figure 9 
was pursued, but instead using the CF3-imidazolium in place of CH3-imidazolium. Since CF3 is a 
strong electron-withdrawing substituent, it draws negative charge towards the CF3 group, making 
the carbocation have a stronger positive charge. This makes the overall imidazolium a stronger 
Lewis acid and theoretically more likely to abstract a hydride. However, results from this study 
indicated that CF3 may have been too strong of a Lewis acid or preferred some other reaction, as 
no Fe-D or Im-D was observed in the NMR (Figure 10). Similar data was obtained for Br, a slightly 
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less electron-withdrawing substituent than CF3.  Based on this data it was hypothesized that an 
imidazolium with a Lewis acidity between CH3-imidazolium and Br-imidazolium would work 
best. 
 
Figure 10. Reactions of the model complex with CF3-imidazolium and Br-imidazolium model substrates. The lack of 
an Im-D peak suggests that hydride transfer to the substrate did not occur. 
 
 One compound that falls within this range is H-imidazolium. Compared to the electron-
donating methyl group and the electron withdrawing bromo group, a proton falls in between. Due 
to its intermediate electronic properties, it was expected that H-imidazolium would have an ideal 
Lewis acidity (between Br- and CH3-imidazolium) to promote full transfer of the deuteride from 
the Fe center. Figure 11 shows the 2H NMR for the reaction.  And indeed, signals at 6.13 ppm and 
5.81 ppm are indicative of Im-D and the phenol O-D respectively. These indicate transfer of the 
hydride to the imidazolium substrate was successful. The important detail, however, is that there 
is no Fe-D peak observed around -15 ppm as seen in the previous NMR spectra. This suggests that 
transfer to H-imidazolium was successful, resulting in formation of the desired imidazolidine 
product. However, there is an additional signal at 4.82 ppm that requires identification before 
making a firm conclusion. A current hypothesis is that the H-imidazolium may have been 
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contaminated with some amidine, which then reacted with the deuterium in this experiment. The 
H-imidazolium is thus being re-crystallized to ensure its purity. After purification, this experiment 
will be repeated to see if the 4.82 ppm resonance will be eliminated. 
 
 
Figure 11. The reaction of the Fe-acyl model complex with H-Imidazolium led to the disappearance of the Fe-D 
signal. The presence of both an Im-D and OD peak suggest complete transfer of the hydride to the substrate may have 
occurred.  
III. Imidazolium as both a Ligand and Substrate 
In order to carry out the reactivity studies with the Fe-hydrogenase model complexes, the 
reactions must be performed in high pressure NMR tubes and the imidazolium and base must be 
added to the reaction. While these studies have proven useful in determining what species are 
present in the reaction, the precise interactions of the complex and substrate must be inferred. In 
order to determine the structural interactions between the complex and substrate, it would be ideal 
to have a crystal structure of both components interacting. To achieve this goal, it was 
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hypothesized that the imidazolium substrate could be covalently positioned close to the Fe center. 
This could allow for easier “co-crystallization” as well as additional reactivity studies.  
 The initial goal was to attach the imidazolium substrate to the Fe complex through a 
phosphine (PPh2) bridge. This will position the substrate close to the Fe center, while still allowing 
some flexibility to react with H2 (or D2) (Figure 12). 
 
Figure 12. Phosphine-substrate model that positions the substrate close to the Fe center. The imidazolium serves as 
both a substrate and ligand. 
 
 One benefit of this approach is that it is a modification to an existing model complex. Either 
the Fe-acyl or Fe-carbamoyl complex can be used, so there is no need for the synthesis of a novel 
anthracene-based ligand or model complex. However, the imidazolium-phosphine ligand did 
require a novel preparation. This was carried out by a 4-step procedure. The first two steps involved 
synthesis of the Br-imidazolium complex from 4-Br-benzoic acid and 2,6-difluoroaniline 
(described in Scheme 2 and 3 above). The third step converted the Br-benzoic acid bromide salt to 
a BArF (Tetrakis[3,5-bis(trifluoromethyl)phenyl]borate) salt (Scheme 6). This made it possible to 
carry out the subsequent lithiation reaction since the Br counterion may have reacted with the 
lithium ions instead of the Br on the imidazolium. Conversion to the BArF salt also helped increase 
solubility. 
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Scheme 6. Conversion of Br-imidazolium bromide salt into BArF salt 
 
The fourth step utilized the functionality of the Br group to attach diphenylphosphine in the para 
position (Scheme 7). In this reaction, the Br group on the imidazolium was first lithiated using n-
butyllithium. A color change from yellow to a dark orange was observed. Upon addition of the 
phosphine source, ClPPh2, the reaction turned back to yellow. After extractions with Et2O, the 
resulting product is a yellow-white powder.  
 
 
 
Scheme 7. Attachment of PPh2 to Br-imidazolium through lithiation and subsequent addition of a phosphine source 
 
This phosphine-imidazolium product has been successfully synthesized but has not yet 
been purified. From the resulting mass spectrometry analysis, the major impurity appears to be H-
imidazolium. This suggests that the lithiation step is successful, but attachment of PPh2 is not 
complete. Increasing the ClPPh2 source to 2 equivalents was unsuccessful at improving purity. As 
the product is air-sensitive, purification by a column is difficult. Therefore, changing the 
stoichiometry of the reactants and modifying the work-up procedure seem to be the next steps for 
obtaining a purer product. After purification, metalation with the Fe-acyl or Fe-carbamoyl complex 
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will be carried out. From there the product can be used for reactivity or X-ray studies to elucidate 
the structural interactions that occur between the model complex and the imidazolium substrate.  
Conclusion 
  In summary, based on this preliminary data, when the Fe-acyl model was combined with a 
model imidazolium substrate of an ideal Lewis acidity, transfer of a hydride to the model substrate 
was observed. Additionally, it was determined that the model substrate helped stabilize the iron-
hydride intermediate during the reaction. These results suggest that the Lewis acidity of the natural 
methenyl-H4MPT
+ substrate and mono-[Fe] hydrogenase plays an important role in H2 activation. 
Reactivity studies with the imidazolium derivatives are currently ongoing, as well as structural 
studies to covalently position the substrate close to the iron complex. Future goals include 
incorporating a pyridone and/or thiolate donor into the ligand backbone to more closely model the 
naturally occurring mono-[Fe] hydrogenase enzyme. 
 
Materials and Methods 
 
All reactions were carried out under N2 using standard Schlenk line and glovebox techniques. The 
included 1H and 19F NMR spectra were collected using a Varian DirectDrive 400 instrument. All 
31P NMR were collected using an Agilent MR 400 instrument.  
 
Synthesis 
N,N-bis(2,6-difluorophenyl)-4-(trifluoromethyl)benzamidine (1) 
Phosphorous pentoxide (15.2 g, 53.7 mmol, 6 eq.) and hexamethyldisiloxane (24.7 mL, 116 mmol, 
13 eq.) were prepared in a 250 mL Schlenk flask. DCM (30 mL) was added in the glovebox and 
the solution was heated to reflux for 1 h under N2. The DCM and any unreacted 
hexamethyldisiloxane were then removed by distillation at 160 °C. To the remaining solution, 4-
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trifluoromethylbenzoic acid (1.70 g, 8.94 mmol, 1 eq.) and 2,6-difluoroaniline (2.41 mL, 22.3 
mmol, 2.5 eq.) were added and the reaction was stirred at 160 °C for 42 hrs. While still hot, the 
viscous tan solution was added to an aqueous solution of KOH (400 mL, 0.5 M) and stirred 
vigorously for 1 h. The mixture was then extracted with DCM (3 x 100 mL), the organic layer 
dried over Na2SO4, and then filtered over neutral aluminum oxide. The solution volume was 
reduced in vacuo and pentane (50 mL) was added to the solution. After storing the solution at -20 
°C for 48 hrs, white crystals were collected by filtration. Washing with pentane afforded 2.28 g of 
white powder (62%). 1H NMR (400 MHz, CDCl3):  δ (ppm) = 7.87 (1 H), 7.56 (3 H), 6.99 (2 H), 
6.83 (4 H), 6.11 (1 H). 19F NMR (CDCl3):  δ (ppm) = -63.02 (s), −119.5 (s), −121.5 (s). HR-MS 
(ESI-MS): Calcd. for [C20H11F7N2+H]+ 413.08830; found: 413.08980. 
4-bromo-N,N'-bis(2,6-difluorophenyl)benzamidine (2) 
Phosphorous pentoxide (14.4 g, 50.8 mmol, 6 eq.) and hexamethyldisiloxane (23.4 mL, 110 mmol 
were prepared in a 250 mL Schlenk flask. DCM (30 mL) was added in the glovebox and the 
solution was heated to reflux for 1 h under N2. The DCM and any unreacted hexamethyldisiloxane 
were then removed by distillation at 160 °C. To the remaining solution, 4-bromobenzoic acid (1.70 
g, 8.46 mmol, 1 eq.) and 2,6-difluoroaniline (2.28 mL, 21.2 mmol, 2.5 eq.) were added and the 
reaction was stirred at 160 °C for 44 hrs. While still hot, the viscous tan solution was added to an 
aqueous solution of KOH (400 mL, 0.5 M) and stirred vigorously for 1 h. The mixture was then 
extracted with DCM (3 x 100 mL), the organic layer dried over Na2SO4, and then filtered over 
neutral aluminum oxide. The solution volume was reduced in vacuo and pentane (50 mL) was 
added to the solution. After storing the solution at -20 °C for 48 hrs, white crystals were collected 
by filtration. Washing with pentane afforded 3.19 g of white powder (89 %). 1H NMR (400 MHz, 
CDCl3):  δ (ppm) = 7.60 (1 H), 7.52 (1 H), 7.42 (d, 2 H), 6.99 (s, 3 H), 6.83 (m, 4 H). 19F NMR 
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(CDCl3):  δ (ppm) = −119.58 (s), −121.53 (s). HR-MS (ESI-MS): Calcd. for [C21H14F7BrF4N2+H]+ 
449.02710; found: 449.0285. 
N,N'-bis(2,6-difluorophenyl)benzamidine (3) 
Phosphorous pentoxide (17.8 g, 62.7 mmol, 6 eq.) and hexamethyldisiloxane (29.0 mL, 137 mmol, 
13 eq.) were prepared in a 250 mL Schlenk flask. DCM (30 mL) was added in the glovebox and 
the solution was heated to reflux for 1 h under N2. The DCM and any unreacted 
hexamethyldisiloxane were then removed by distillation at 160 °C. To the remaining solution, 
benzoic acid (1.28 g, 10.5 mmol, 1.0 eq.) and 2,6-difluoroaniline (2.82 mL, 26.25 mmol, 2.5 eq.) 
were added and the reaction was stirred at 160 °C for 44 hrs. While still hot, the viscous tan solution 
was added to an aqueous solution of KOH (400 mL, 0.5 M) and stirred vigorously for 1 h. The 
mixture was then extracted with DCM (3 x 100 mL), the organic layer dried over Na2SO4, and 
then filtered over neutral aluminum oxide. The solution volume was reduced in vacuo and pentane 
(50 mL) was added to the solution. After storing the solution at -20 °C for 24 hrs, white crystals 
were collected by filtration. Washing with pentane afforded 2.49 g of white powder (69%). 
N,N'-bis(2,6-difluorophenyl)-4-methylbenzamidine (4) 
Synthesis of this compound was carried out using the procedure from Meyer et al.12 Phosphorous 
pentoxide (21.3 g, 75.0 mmol, 6 eq.) and hexamethyldisiloxane (34.2 mL, 160 mmol, 13 eq.) were 
prepared in a 250 mL Schlenk flask. DCM (30 mL) was added in the glovebox and the solution 
was heated to reflux for 1 h under N2. The DCM and any unreacted hexamethyldisiloxane were 
then removed by distillation at 160 °C. To the remaining solution, p-toluic acid (1.70 g, 12.5 mmol, 
1.0 eq.) and 2,6-difluoroaniline (3.39 mL, 31.4 mmol, 2.5 eq.) were added and the reaction was 
stirred at 160 °C for 40 hrs. While still hot, the viscous tan solution was added to an aqueous 
solution of KOH (400 mL, 0.5 M) and stirred vigorously for 1 h. The mixture was then extracted 
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with DCM (3 x 100 mL), the organic layer dried over Na2SO4, and then filtered over neutral 
aluminum oxide. The solution volume was reduced in vacuo and pentane (50 mL) was added to 
the solution. After storing the solution at -20 °C for 24 hrs, white crystals were collected by 
filtration. Washing with pentane afforded 2.77 g of white powder (62 %). This product is a mixture 
of two isomers. Only the major isomer data is reported. 1H NMR (400 MHz, CDCl3):  δ (ppm) = 
7.30 (d, 2 H), 7.17 (d, 1 H), 7.10 (d, 2H), 6.94 (m, 2 H), 6.84–6.76 (m, 3 H), 6.16 (s, 1 H), 2.31 (s, 
3 H). 19F NMR (CDCN3):  δ (ppm) = −119.57 (s), −121.63 (s). HR-MS (ESI-MS): Calcd. for 
[C20H14F4N2+H]+ 359.11660; found: 359.11690. 
N,N'-bis(2,6-difluorophenyl)-4-methoxybenzamidine (5) 
Phosphorous pentoxide (19.1 g, 67.2 mmol, 6 eq.) and hexamethyldisiloxane (30.9 mL, 146 mmol, 
13 eq.) were prepared in a 250 mL Schlenk flask. DCM (30 mL) was added in the glovebox and 
the solution was heated to reflux for 1 h under N2. The DCM and any unreacted 
hexamethyldisiloxane were then removed by distillation at 160 °C. To the remaining solution, 4-
methoxybenzoic acid (1.70 g, 11.2 mmol, 1.0 eq.) and 2,6-difluoroaniline (3.0 mL, 27.7 mmol, 2.5 
eq.) were added and the reaction was stirred at 160 °C for 44 hrs. While still hot, the viscous tan 
solution was added to an aqueous solution of KOH (400 mL, 0.5 M) and stirred vigorously for 1 
h. The mixture was then extracted with DCM (3 x 100 mL), the organic layer dried over Na2SO4, 
and then filtered over neutral aluminum oxide. The solution volume was reduced in vacuo and 
pentane (50 mL) was added to the solution. After storing the solution at -20 °C for 48 hrs, white 
crystals were collected by filtration. Washing with pentane afforded 3.05 g of white powder (73%). 
1H NMR (400 MHz, CDCl3):  δ (ppm) = 7.71 (d, 1 H), 7.37 (d, 2 H), 6.95 (m, 2 H), 6.88–6.78 (m, 
8 H), 6.05 (s, 1 H), 3.77 (s, 3 H). 19F NMR (CDCl3):  δ (ppm) = -119.73, -121.69. HR-MS (ESI-
MS): Calcd. for [C20H14F4N2O+H]+ 375.11150; found: 375.11170. 
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1,3-bis(2,6-difluorophenyl)-2-(4-(trifluoromethyl)phenyl)-4,5-dihydro-1H-imidazol-3-ium 
Bromide (6) 
1,2-dibromoethane (5 mL) was added to a Schlenk flask containing N,N-bis(2,6-difluorophenyl)-
4-(trifluoromethyl)benzamidine (1.0 g, 2.4 mmol) and the reaction was heated to reflux for 58 hrs. 
After removing the solvent in vacuo, the crude solid was dissolved in DCM (15 mL) and washed 
with aqueous NaHCO3 (15 mL). The organic layer was extracted with DCM (3x15 mL), dried over 
Na2SO4, and concentrated in vacuo. Addition of Et2O (5 mL) precipitated a tan solid that was 
collected by decanting the Et2O layer and washing the solid with Et2O (3x3 mL). The product was 
recrystallized at room temperature by layering DCM/Et2O (5 mL/ 5 mL) to afford 0.182 g (17%) 
of light yellow solid. The remaining Et2O layer contains unreacted benzamidine. 
1H NMR (400 
MHz, CD3CN):  δ (ppm) = 7.58 (d, 2 H), 7.50–7.42 (m, 4 H), 7.07-7.02 (m, 4 H), 4.62 (s, 4 H). 
19F NMR (CD3CN):  δ (ppm) = -64.28 (s), −118.01 (s). HR-MS (ESI-MS): Calcd. for 
[C22H14F7N2+H]+ 439.10400; found: 439.10520. 
2-(4-bromophenyl)-1,3-bis(2,6-difluorophenyl)-4,5-dihydro-1H-imidazol-3-ium Bromide (7) 
1,2-dibromoethane (5 mL) was added to a Schlenk flask containing 4-bromo-N,N'-bis(2,6-
difluorophenyl)benzamidine (1.0 g, 2.4 mmol) and the reaction was heated to reflux for 56 hrs. 
After removing the solvent in vacuo, the crude solid was dissolved in DCM (15 mL) and washed 
with aqueous NaHCO3 (15 mL). The organic layer was extracted with DCM (3x15 mL), dried over 
Na2SO4, and concentrated in vacuo. Addition of Et2O (5 mL) precipitated a tan solid that was 
collected by decanting the Et2O layer and washing the solid with Et2O (3x3 mL). The product was 
recrystallized at room temperature by layering DCM/Et2O (5 mL/ 5 mL) to afford 0.363 g (34%) 
of tan solid. The remaining Et2O layer contains unreacted benzamidine. 
1H NMR (400 MHz, 
CD3CN):  δ (ppm) = 7.59-7.55 (m, 4 H), 7.24 (d, 2 H), 7.18-7.13 (m, 4 H), 4.68 (s, 4 H).19F NMR 
28 
 
(CD3CN):  δ (ppm) = −118.2. HR-MS (ESI-MS): Calcd. for [C21H14BrF4N2+H]+ 449.02710; 
found: 449.02850. 
1,3-bis(2,6-difluorophenyl)-2-phenyl-4,5-dihydro-1H-imidazol-3-ium Bromide (8) 
1,2-dibromoethane (5 mL) was added to a Schlenk flask containing N,N'-bis(2,6-
difluorophenyl)benzamidine (1.0 g, 2.9 mmol) and the reaction was heated to reflux for 52 hrs. 
After removing the solvent in vacuo, the crude solid was dissolved in DCM (15 mL) and washed 
with aqueous NaHCO3 (15 mL). The organic layer was extracted with DCM (3x15 mL), dried over 
Na2SO4, and concentrated in vacuo. Addition of Et2O (5 mL) precipitated a white solid that was 
collected by decanting the Et2O layer and washing the solid with Et2O (3x3 mL). The product was 
recrystallized at room temperature by layering DCM/Et2O (5 mL/ 5 mL) to afford 0.215 g (20%) 
of tan solid. The remaining Et2O layer contains unreacted benzamidine. 
1H NMR (400 MHz, 
CDCl3):  δ (ppm) = 7.52 (m, 1 H), 7.45-7.39 (m, 1 H), 7.32 (t, 3 H), 7.24 (1 H), 7.22 (1 H), 7.03-
6.99 (m, 3 H), 5.13 (s, 4H). 19F NMR (CDCl3):  δ (ppm) = -116.73. HR-MS (ESI-MS): Calcd. for 
[C21H15F4N2+H]+ 371.11660; found: 371.11680. 
1,3-bis(2,6-difluorophenyl)-2-(p-tolyl)-4,5-dihydro-1H-imidazol-3-ium Bromide (9) 
Synthesis of this compound was carried out using the procedure from Meyer et al.12 1,2-
dibromoethane (5 mL) was added to a Schlenk flask containing N,N'-bis(2,6-difluorophenyl)-4-
methylbenzamidine (1.0 g, 2.8 mmol) and the reaction was heated to reflux for 52 hrs. After 
removing the solvent in vacuo, the crude solid was dissolved in DCM (15 mL) and washed with 
aqueous NaHCO3 (15 mL). The organic layer was extracted with DCM (3x15 mL), dried over 
Na2SO4, and concentrated in vacuo. Addition of Et2O (5 mL) precipitated a tan solid that was 
collected by decanting the Et2O layer and washing the solid with Et2O (3x3 mL). The product was 
recrystallized at room temperature by layering DCM/Et2O (5 mL/ 5 mL) to afford 0.422 g (39%) 
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of tan solid. The remaining Et2O layer contains unreacted benzamidine. 
1H NMR (400 MHz, 
CDCl3):  δ (ppm) = 7.47-7.39 (m, 2 H), 7.10 (s, 4 H), 7.01 (t, 4 H), 5.09 (s, 4 H), 2.30 (s, 3 H). 19F 
NMR (400 MHz):  δ (ppm) = -116.84.  
1,3-bis(2,6-difluorophenyl)-2-(4-methoxyphenyl)-4,5-dihydro-1H-imidazol-3-ium Bromide 
(10) 
1,2-dibromoethane (5 mL) was added to a Schlenk flask containing N,N'-bis(2,6-difluorophenyl)-
4-methoxybenzamidine (1.0 g, 2.7 mmol) and the reaction was heated to reflux for 52 hrs. After 
removing the solvent in vacuo, the crude solid was dissolved in DCM (15 mL) and washed with 
aqueous NaHCO3 (15 mL). The organic layer was extracted with DCM (3x15 mL), dried over 
Na2SO4, and concentrated in vacuo. Addition of Et2O (5 mL) precipitated a tan solid that was 
collected by decanting the Et2O layer and washing the solid with Et2O (3x3 mL). The product was 
recrystallized at room temperature by layering DCM/Et2O (5 mL/ 5 mL) to afford 0.211 g (20%) 
of tan solid. The remaining Et2O layer contains unreacted benzamidine. 
1H NMR (400 MHz, 
CDCl3):  δ (ppm) = 7.48-7.40 (m, 2 H), 7.14 (d, 2 H), 7.03 (m, 4 H), 6.79 (d, 2 H), 5.05 (s, 4 H), 
3.77 (s, 3 H). 19F NMR (CDCl3):  δ (ppm) = -116.81 
1,3-bis(2,6-difluorophenyl)-2-(4-diphenylphosphaneyl)phenyl)-4,5-dihydro-1H-imidazol-3-
ium BArF (11) 
To a vial of 2-(4-bromophenyl)-1,3-bis(2,6-difluorophenyl)-4,5-dihydro-1H-imidazol-3-ium 
(0.100 g, 0.22 mmol, 1 eq.) in Et2O (15 mL), NaBArF (0.195 g, 0.22 mmol, 1 eq.) dissolved in 
Et2O (2 mL) was added and the mixture was stirred for 10 minutes. The precipitated NaBr was 
removed by filtering the light beige solution through a celite-packed pipet into a 50 mL Schlenk 
flask. The reaction was performed under N2 and cooled to -70 °C in a dry ice/acetone bath. N-
Butyllithium (0.14 mL, 0.22 mmol) was added dropwise to the flask and the solution stirred at -70 
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°C for 1 h. Upon addition of n-BuLi, the reaction changed from a light yellow to a dark orange 
color. Chlorodiphenylphosphine (0.04 mL, 0.22 mmol) was then added dropwise at -70 °C and the 
solution was allowed to slowly warm to room temperature. After stirring for 20 hrs, degassed H2O 
(5 mL) was added to the reaction and stirred for 10 minutes, turning the solution from an opaque 
white solution to clear yellow. The Et2O layer from the reaction flask was then transferred to a 
new 50 mL Schlenk flask containing Na2SO4 and already under a N2 atmosphere. After a few 
minutes, the Et2O layer was removed in vacuo with a cold trap. The flask was brought into the 
glovebox, the solid re-dissolved in Et2O, and filtered through a celite-packed pipet. The Et2O was 
removed in vacuo to yield a yellow-white solid. The NMR is reported for the major signals in the 
crude product as purification has been unsuccessful. 1H NMR (400 MHz, CDCl3):  δ (ppm) = 8.65 
(s), 7.72–7.63 (m), 7.59-7.55 (m), 7.50-7.43 (m), 7.15 (m) 6.92 (m), 5.28 (s), 4.53 (s). 19F NMR 
(CDCl3):  δ (ppm) = -62.48, -117.85. 31P NMR (400 MHz, CDCl3):  δ (ppm) = 22.88, -19.10, -
19.39, -40.39. HR-MS (ESI-MS): Calcd. for [C33H24F4N2P+H]+ 555.16300; found: 555.16080. 
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Supplementary Figure 1. 19F NMR CF3-amidine in CDCl3  
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Supplementary Figure 2. 1H NMR CF3-amidine in CDCl3  
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Supplementary Figure 3. 1H NMR CF3-imidazolium in CD3CN  
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Supplementary Figure 4. 19F NMR CF3-imidazolium in CD3CN  
 
Supplementary Figure 5. ESI Mass Spectrometry CF3-imidazolium: Observed Mass 439.10520, 
Calculated Mass: 439.10400 
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Supplementary Figure 6. ESI Mass Spectrometry CF3-amidine: Observed Mass 413.08980, Calculated 
Mass: 413.08830 
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Supplementary Figure 7. 19F NMR Br-imidazolium in CD3CN  
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Supplementary Figure 8. 1H NMR Br-imidazolium in CD3CN  
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Supplementary Figure 9. 1H NMR Br-amidine in CDCl3  
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Supplementary Figure 10. 19F NMR CF3-imidazolium in CDCl3  
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Supplementary Figure 11. ESI Mass Spectrometry Br-amidine: Observed Mass 423.01170, Calculated 
Mass: 423.01150 
 
 
Supplementary Figure 12. ESI Mass Spectrometry Br-amidine: Observed Mass 449.0285, Calculated 
Mass: 449.02710 
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Supplementary Figure 13. 19F NMR H-imidazolium in CDCl3  
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Supplementary Figure 14. 1H NMR H-imidazolium in CDCl3  
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Supplementary Figure 15. 19F NMR H-imidazolium in CDCl3  
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Supplementary Figure 16. 1H NMR OMe-imidazolium in CDCl3  
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Supplementary Figure 17. 1H NMR OMe-amidine in CDCl3  
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Supplementary Figure 18. 19F NMR CH3-amidine in CDCl3  
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Supplementary Figure 19. 19F NMR OMe-amidine in CDCl3  
 
amidine 
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Supplementary Figure 20. 1H NMR CH3-amidine in CDCl3  
 
amidine 
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Supplementary Figure 21. 19F NMR CH3-imidazolium in CDCl3  
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Supplementary Figure 22. 1H NMR CH3-imidazolium in CDCl3  
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Supplementary Figure 23. 31P NMR PPh2-imidazolium in CDCl3  
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Supplementary Figure 24. 1H NMR PPh2-imidazolium in CDCl3  
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Supplementary Figure 25. 19F NMR PPh2-imidazolium in CDCl3  
 
